| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/10/1992 | US5094785 Process for stabilizing liposomes |
| 03/10/1992 | CA1297038C Foamable creams |
| 03/10/1992 | CA1297035C Chewable, non-gritty calcium citrate tablet |
| 03/10/1992 | CA1297029C Topical metronidazole formulations and therapeutical uses thereof |
| 03/10/1992 | CA1297027C Vaginal suppository |
| 03/10/1992 | CA1297026C Brompheniramine, pseudoephedrine therapy |
| 03/10/1992 | CA1297025C Controlled release hydromorphone composition |
| 03/10/1992 | CA1297020C Estradiol implant composition and method for preparation |
| 03/10/1992 | CA1297019C Method for the preparation of sustained release bolus formulation |
| 03/10/1992 | CA1297018C Pharmaceutical composition |
| 03/10/1992 | CA1297017C Controlled release pharmaceutical composition |
| 03/10/1992 | CA1297016C Sustained release pharmaceutical preparations |
| 03/10/1992 | CA1297015C Sustained release tablets and method of making same |
| 03/10/1992 | CA1297014C Multilamellar liposomes having improved trapping efficiencies |
| 03/10/1992 | CA1297013C Ointment base |
| 03/10/1992 | CA1297012C Pharmaceutical compositions for inhalation |
| 03/10/1992 | CA1296966C O/w type emulsion composition |
| 03/10/1992 | CA1296868C Process for preparing soluble and/or splitable tablets and tabletsthus obtained |
| 03/08/1992 | CA2050689A1 Chewable spheroidal coated microcapsules and methods for preparing same |
| 03/06/1992 | WO1992004019A1 Topical treatment and composition |
| 03/06/1992 | CA2090974A1 Topical treatment and composition |
| 03/05/1992 | WO1992004031A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003172A1 Dressing system |
| 03/05/1992 | WO1992003162A1 Vaccines |
| 03/05/1992 | WO1992003141A1 Topical compositions and methods for treatment of male impotence |
| 03/05/1992 | WO1992003133A1 Topical treatment of blepharitis |
| 03/05/1992 | WO1992003126A1 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
| 03/05/1992 | WO1992003124A1 Controlled release formulations and method |
| 03/05/1992 | WO1992003123A1 Liposome alternative bilayer formulations |
| 03/05/1992 | WO1992003122A1 Preparation for application of active substances in the form of minimum-sized droplets |
| 03/05/1992 | WO1992003121A1 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/04/1992 | EP0473431A1 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
| 03/04/1992 | EP0473395A1 Use of Rhamsan gum for the manufacture of a teat treating composition |
| 03/04/1992 | EP0473268A2 Continuous release pharmaceutical compositions comprising a polypeptide covalently conjugated to a water soluble polymer |
| 03/04/1992 | EP0473223A1 Bioerodible implants |
| 03/04/1992 | EP0473159A1 Stable aqueous preparation |
| 03/04/1992 | EP0472969A1 External preparation comprising calcium silicate |
| 03/04/1992 | EP0472772A1 Process for the preparation of vital drug-laden human erythrocytes |
| 03/04/1992 | EP0472639A1 Accumulation of drugs into liposomes by a proton gradient |
| 03/04/1992 | EP0472575A1 Improvements in or relating to pharmaceutical preparations |
| 03/04/1992 | CN1059101A Lotion for tinea ficosa dampness |
| 03/04/1992 | CA2050425A1 Pharmaceutical composition and its mucous use |
| 03/03/1992 | US5093485 Polysaccharide-based composition and its use |
| 03/03/1992 | US5093372 Used in treatment of dementia, improved solubility, absorption cellulose ethers |
| 03/03/1992 | US5093348 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
| 03/03/1992 | US5093316 Inhalation of alpha-1-antitrypsin and other serine protease inhibitors |
| 03/03/1992 | US5093200 Multilayer sustained release granule |
| 03/03/1992 | US5093198 Adjuvant-enhanced sustained release composition and method for making |
| 03/03/1992 | US5093133 Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| 03/03/1992 | US5093132 Stabilized pharmaceutical composition and its production |
| 03/03/1992 | US5093128 Rumen and other stomach chamber bypass nutrients and methods of fabrication |
| 03/03/1992 | US5093126 Sustained release, beta blockers |
| 03/03/1992 | US5093099 Flaky powder of zinc oxide and its composition for external use |
| 03/03/1992 | US5093043 Process for preparing nonionic surfactants |
| 03/03/1992 | CA1296686C Cassette system and apparatus for manufacturing an active agent liberating capsule for subcutaneous use |
| 03/03/1992 | CA1296635C Pharmaceutical composition containing quinoline dicarboxylic acid derivatives |
| 03/03/1992 | CA1296634C Pharmaceutical formulations of ciprofloxacin |
| 03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
| 03/03/1992 | CA1296632C Controlled release drug-containing fibers |
| 03/03/1992 | CA1296631C Controlled-release composition |
| 03/03/1992 | CA1296630C Dual phase solvent carrier system |
| 03/03/1992 | CA1296629C Ocular treatment |
| 03/03/1992 | CA1296628C Ethanol fill formulation for softgels containing vitamins, dietary supplements and the like |
| 03/03/1992 | CA1296627C Compositions for parenteral administration and their use |
| 03/01/1992 | WO1992004032A1 Slow release compositions |
| 03/01/1992 | WO1992004024A2 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | WO1992004016A1 Pharmaceutical composition of florfenicol |
| 03/01/1992 | CA2090613A1 Slow release compositions |
| 03/01/1992 | CA2089158A1 Toxic agent protective compounds, compositions and method |
| 03/01/1992 | CA2049524A1 Compositions comprising a hydrophillic polymer and a hydrophillic material different therefrom |
| 02/28/1992 | CA2049817A1 Gemfibrozil formulations |
| 02/26/1992 | EP0472502A1 Process for obtaining granules |
| 02/26/1992 | EP0472428A2 Low moisture chewing gum |
| 02/26/1992 | EP0472327A1 Composition for eye drops |
| 02/26/1992 | EP0472225A2 Hydrated lammelar lipidic phases or liposomes containing tretinoid |
| 02/26/1992 | EP0471967A1 Chewable tablet containing sucralfate |
| 02/26/1992 | EP0471872A1 Antifungal gel formulations |
| 02/26/1992 | EP0471767A1 Temperature-activated adhesive assemblies. |
| 02/26/1992 | EP0471718A1 Pharmaceutical composition with a paracetamol base. |
| 02/26/1992 | EP0471668A1 Device for the transdermal delivery of nicotine |
| 02/26/1992 | CN1058910A Prescription of spraying agent for preventing sexual disease and its process |
| 02/26/1992 | CN1058909A Prescription of suppository for curing cervix rotten and its process |
| 02/26/1992 | CN1058904A Coated solid medicament form having releasability in large intestine |
| 02/26/1992 | CN1015596B Preparation of riboflavin, produced by microbial method, in form of spray-dried granules of microgranules |
| 02/25/1992 | WO1992003167A1 Coating base for pharmaceutical film and production thereof |
| 02/25/1992 | US5091565 Poly-dicaboxylic acid anhydrides, their production and use |
| 02/25/1992 | US5091417 Preventive and therapeutic agent for hepatitis |
| 02/25/1992 | US5091402 Use of substituted imidazoles |
| 02/25/1992 | US5091379 Dermatitis, side effect reduction |
| 02/25/1992 | US5091373 Administering sterile injectable solution of water, doxorubicin or salts and cosolubilizing agent; lyophilization |
| 02/25/1992 | US5091372 Method of treating tumors with pharmaceutical composition containing anthracycline glycosides |
| 02/25/1992 | US5091193 Zinc oxide, phytic acid and an ester of a fatty alcohol as anti-enzyme |
| 02/25/1992 | US5091191 Pharmaceutical composition with improved dissolution property |
| 02/25/1992 | US5091190 Delivery system for administration blood-glucose lowering drug |
| 02/25/1992 | US5091189 Tablet contains 3-alkylxanthine, hydrophilic or hydrophobic polymers, and wax from the group consists of polyalkylene glycol |
| 02/25/1992 | US5091188 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091187 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091186 Delivers drug at therapeutic rate in initial phase, no drug in secondary phase |